On 14 December, the JPND-funded project EU-FINGERS held its general assembly meeting online. Chaired by Professor Miia Kivipelto, the EU-FINGERS project leader, the online meeting welcomed over 30 project participants, including representatives from the 8 institutions and organisations that make up the EU-FINGERS consortium.
EU-FINGERS is looking at the topics of brain health as people age and the reduction of risk factors related to Alzheimer’s disease and dementia. The project builds on the work of existing, pioneering European intervention studies, and proposes a novel multimodal precision prevention toolbox to address the complex and heterogeneous nature of Alzheimer´s disease and dementia
During the consortium meeting, representatives from the different work packages in the project provided summaries of ongoing activities and briefly discussed their planned work.
Alzheimer Europe (AE) is involved in the Patient and Public Involvement (PPI) activities of the project and in this context, is setting up an Advisory Board to provide relevant input to the researchers from the perspective of people with Alzheimer’s disease across the disease continuum. AE is also co-leading the communication activities of the project. Jean, Dianne, Ana and Cindy took part in the meeting. Alzheimer Europe’s participation is supported by the Luxembourg national research Fund (FNR).
EU-FINGERS is also growing, as a new institution - the University of Luxemburg - has been welcomed in the consortium as an external collaborator. The University of Luxemburg runs a Programm Demenz Prävention (Dementia Prevention Program) led by Professor Rejko Krueger. The program is aligned with the EU-FINGERS principles, adding to the expertise and data library of EU-FINGERS.
EURO-FINGERS is an EU Joint Programme - Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND - www.jpnd.eu: Finland, Academy of Finland; Germany, Federal Ministry of Education and Research; Spain, National Institute of Health Carlos III; Luxemburg, National Research Fund; Hungary, National Research, Development and Innovation Office; The Netherlands, Netherlands Organisation for Health Research and Development; Sweden, Swedish Research Council.
